Gianluca Gessoni, Giulia de Fusco, Giovanni Roveroni, Carla Rossi, Gabriella Mazzaro, Lauretta Moro, Gianni Tidore, Marta Siviero, Giovanni Carretta, Domenico Bagnara, Raffaella Berti & Silvia da Ros·International Blood Research & Reviews·2026
Background: In contemporary healthcare systems, the sustainability of complex care models increasingly depends on the transition toward decentralized frameworks. Community-based transfusion therapy have emerged as a strategic approach to ensure continuity of care for frail and ch...
Open access
Research Article10.9734/ibrr/2026/v17i2379
Gianluca Gessoni, Giovanni Roveroni, Lauretta Moro, Michela Pivetta, Michele Tessarin, Domenico Bagnara, Sara Valverde, Rossi Carla, Coluccia Enza, Collodel Luca, Roberto Valle & Giovanni Carretta·International Blood Research & Reviews·2023
Aims: This case-control prospective study aimed to describe the effects of COVID convalescent plasma (CCP) on late mortality in hospitalized patients with coronavirus disease 2019 (COVID-19) pneumonia. Study Design: In this study were enrolled 214 consecutive patients with moder...
Open access
Research Article10.9734/ibrr/2023/v14i2305
Gianluca Gessoni, Giovanni Roveroni, Lauretta Moro, Michela Pivetta, Michele Tessarin, Domenico Bagnara, Sara Valverde, Rossi Carla, Coluccia Enza, Collodel Luca, Roberto Valle & Giovanni Carretta·International Blood Research & Reviews·2023
Background: This was a single center prospective study about factors related with mortality in hospitalized patients with severe COVID-19 pneumonia treated with convalescent plasma (CCP) infusion in Venice Prefecture. Methods: In this study were enrolled all the (376) consecutive...
Open access
Research Article10.9734/ibrr/2023/v14i2302
Background: CD38 is a protein highly expressed on myeloma (MM) cells that has been shown to be an effective target antigen for monoclonal antibody therapies, so treatment with anti-CD38 monoclonal antibodies is a first line therapy for patients with MM. Although CD38 is weaker ex...
Open access
Research Article10.9734/ibrr/2024/v15i3343
Background: A considerable number of RHD alleles responsible for weak and partial D phenotypes have been identified. Serological determination of these phenotypes is often doubtful and makes genetic analysis of RHD gene highly desirable in transfusion recipients and pregnant wome...
Open access
Research Article10.9734/ibrr/2024/v15i2337
Background: Few reports have been published about the current clinical management of anti-Kell alloimmunization in pregnancy; its low frequency of occurrence means that the few long series published have covered an extensive time period in which different treatment approaches ha...
Open access
Research Article10.9734/ibrr/2024/v15i3339